CalciMedica, Inc. - Common Stock (CALC)

CUSIP: 38942Q202

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 5 signals
Share change
+3,030,591
SEC-reported price per share
$4.16
Indexed holders
19
Value change
+$12,607,257
Number of buys
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,159,407

Security key

38942Q202

Report period

Q1 2024

Indexed institutions

19

Top holders

10

Ownership snapshot

Top reported holders of CALC - CalciMedica, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sanderling Venture Partne...
Disclosed value leader
Sanderling Venture Partne...
Comparable rows
0/15
Latest evidence
23 Jan 2024
3/4/5 13F Highest disclosed value: $8,526,033 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Sanderling Venture Partners VI LP has the largest disclosed position value at $8.53M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sanderling Venture Partners VI LP's linked filing trail.
Disclosed position value Top 5
Sanderling Venture Partners VI LP $8.53M
Valence Investments SPV IV LLC $2.74M
ORBIMED ADVISORS LLC $850.5K
BML Capital Management, LLC $415.9K
MERITAGE PORTFOLIO MANAGEMENT $132K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sanderling Venture Partners VI LP
3/4/5
10%+ Owner
—
mixed-class rows
$8,526,033
2,642,780 shares
mixed-class rows
— 23 Jan 2024
Valence Investments SPV IV LLC
3/4/5
10%+ Owner
—
mixed-class rows
$2,736,985
749,261 shares
mixed-class rows
— 20 Mar 2023
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$850,507
297,380 shares
— 31 Dec 2023
BML Capital Management, LLC
13F
Company
13F
—
denominator unverified
$415,913
145,424 shares
— 31 Dec 2023
MERITAGE PORTFOLIO MANAGEMENT
13F
Company
13F
—
denominator unverified
$132,000
46,000 shares
— 31 Dec 2023
Robert S. Breuil
3/4/5
Chief Financial Officer
—
denominator unverified
$130,777
35,326 shares
— 23 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
19
Shares
3,547,369
Indexed holders
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
10
Q1 2024 indexed holders
19
Indexed holder difference
9
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .